Company: APM
Filing Date: 2025-10-06
Form Type: S-4
Source: 0001213900-25-096656
Chunk: 224

Company: Aptorum Group Ltd
Filing Date: 2025-10-06
Form: S-4
Chunk 224
---
 impede the Merger from qualifying for the Intended Tax Treatment, in each case except in the ordinary course of business consistent with its past practice; or •enter into any Contract that would conflict with the requirement to continue to operate its business in the ordinary course. In addition, except as otherwise specifically contemplated by the Merger Agreement, disclosure schedules, or other transaction documents, as may be required by law, or unless the otherwise consented by DiamiR in writing, Aptorum must not and must cause each of its subsidiaries not to: •change or amend its Organizational Documents except as expressly contemplated by the Transaction Agreements; •(A) declare, set aside, establish a record date for, make or pay any dividend or other distribution, payable in cash, shares, property or otherwise in respect of any outstanding equity securities; (B) except for the conversion of Aptorum Class B Ordinary Shares into Aptorum Class A ordinary Shares that is initiated by shareholder(s) of Aptorum, issue, sell, grant, or offer to issue, sell, grant any equity securities and (ii) the issuance of shares of Aptorum Common Stock following the Domestication issue, sell, grant, or offer to issue, sell, grant any equity securities, provided, however, each of Aptorum and the DiamiR agree to cooperate to raise additional capital of Aptorum through the sale and issuance of equity securities of Aptorum, provided, further however, the parties agree that any such sale of equity securities of Aptorum 111 following the date of the merger agreement shall dilute each of Aptorum and the DiamiR by 30% and 70%, respectively, so that the Conversion Ratio shall be adjusted to reflect such issuances and dilutions as set forth in this provision. Additionally, any issuances of equity securities under this provision requires the affirmative approval in writing by each of DiamiR and Aptorum. For the sake of clarity, although Aptorum is a party to a Sales Agreement with H.C. Wainwright, no sales under such Sales Agreement have occurred since 2023 and Aptorum is not currently contemplating making sales under the Sales Agreement, additionally, while Aptorum and Diamir have discussed potential public and private sales of securities, there is no currently contemplated financing and no financing is required to close the Merger; (C) split, subdivide, combine or reclassify any equity securities, or amend any terms of any equity securities; or (D) repurchase, redeem or otherwise acquire, or offer to